Home/Investors/Wellington Management

Wellington Management

Biotech Investor · 2 portfolio companies

Portfolio

2

Combined Value

$2.5B

Focus Areas

5

Top Stage

Phase 1/2

Investment Focus

Hematology Oncology Genetic Disorders Metabolic Diseases Liver Diseases

Portfolio Companies

Company	Stage	Valuation	Focus
Beam Therapeutics	Phase 1/2	$2.5B	Hematology, Oncology
Carisma Therapeutics	Phase 1	$1.5M	Oncology

Frequent Co-Investors

BlackRock1 shared Atlas Venture1 shared Arch Venture Partners1 shared Third Rock Ventures1 shared Fidelity Management & Research Company1 shared Pfizer1 shared Apellis Pharmaceuticals1 shared AbbVie Ventures1 shared